These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 6609684
1. Effect of etretinate on the distribution of Langerhans cells and T. lymphocytes in psoriatic skin. Ranki A, Lauharanta J, Kanerva L. Arch Dermatol Res; 1984; 276(2):102-4. PubMed ID: 6609684 [No Abstract] [Full Text] [Related]
2. Effect of etretinate on peripheral T lymphocytes in psoriatic patients before, during and after 6 months of therapy. David M, Shohat B, Hodak E, Sandbank M. Dermatologica; 1990; 180(2):86-9. PubMed ID: 2138096 [Abstract] [Full Text] [Related]
3. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin. Czernielewski J, Juhlin L, Shroot S, Brun P. Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430 [Abstract] [Full Text] [Related]
4. Evaluation of lymphocyte subpopulations with monoclonal antibodies in five psoriatic patients treated with etretinate. Lazzini C, Trevisan G, de Luyk S, Mangiarotti M. Ric Clin Lab; 1984; 14(3):323-5. PubMed ID: 6335285 [No Abstract] [Full Text] [Related]
5. Successful treatment of a patient with Reiter's syndrome and acquired immunodeficiency syndrome using etretinate. Belz J, Breneman DL, Nordlund JJ, Solinger A. J Am Acad Dermatol; 1989 May; 20(5 Pt 2):898-903. PubMed ID: 2785542 [Abstract] [Full Text] [Related]
9. A combined regimen of etretinate and UVB modulate T6+ and HLA-DR+ epidermal cells. Kim YH, Kim CW, Houh W. J Korean Med Sci; 1987 Jun; 2(2):89-96. PubMed ID: 3271057 [Abstract] [Full Text] [Related]
10. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies. Guzman de Fleury M, Tapia FJ, Soto J, Ghersi N, Convit J. Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536 [Abstract] [Full Text] [Related]
12. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)]. Castel T, Castro J, Lecha M, Mascaró JM. Med Cutan Ibero Lat Am; 1986 Jul; 14(2):83-6. PubMed ID: 2943953 [Abstract] [Full Text] [Related]
13. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes. Ellis CN, Kang S, Grekin RC, LoBuglio AF, Voorhees JJ. Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133 [Abstract] [Full Text] [Related]
14. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up. Chieregato GC, Leoni A. Acta Derm Venereol; 1986 Jul; 66(4):321-4. PubMed ID: 2430403 [Abstract] [Full Text] [Related]
15. Epidermal Langerhans' cells in patients with pustulosis palmoplantaris treated with etretinate or etretinate + methoxsalen photochemotherapy. Rosén K, Jontell M, Mobacken H, Rosdahl I. Acta Derm Venereol; 1988 Jul; 68(3):218-23. PubMed ID: 2455414 [Abstract] [Full Text] [Related]